{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:59:26Z","timestamp":1785495566279,"version":"3.56.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,8,20]]},"DOI":"10.1038\/s41416-026-03473-3","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:08:57Z","timestamp":1778854137000},"page":"559-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lethal clinical outcome and immuno-fibrotic contexture in refractory urothelial carcinoma harboring MYC amplification and overexpression"],"prefix":"10.1038","volume":"135","author":[{"given":"Lingkai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5288-5037","authenticated-orcid":false,"given":"Zhaopei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohe","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-6516","authenticated-orcid":false,"given":"Kaifeng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6486-2038","authenticated-orcid":false,"given":"Han","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3494-3114","authenticated-orcid":false,"given":"Weijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8833-3541","authenticated-orcid":false,"given":"Zewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7431-9063","authenticated-orcid":false,"given":"Jiejie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"3473_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"3473_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","volume":"79","author":"JA Witjes","year":"2021","unstructured":"Witjes JA, Bruins HM, Cathomas R, Comperat EM, Cowan NC, Gakis G, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol. 2021;79:82\u2013104.","journal-title":"Eur Urol"},{"key":"3473_CR3","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1097\/PAS.0000000000002053","volume":"48","author":"JI Warrick","year":"2024","unstructured":"Warrick JI, Al-Ahmadie H, Berman DM, Black PC, Flaig TW, H\u00f6glund M, et al. International Society of Urological Pathology Consensus Conference on Current Issues in Bladder Cancer. Working Group 4: Molecular Subtypes of Bladder Cancer-Principles of Classification and Emerging Clinical Utility. Am J Surg Pathol. 2024;48:e32\u2013e42.","journal-title":"Am J Surg Pathol"},{"key":"3473_CR4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41568-022-00530-w","volume":"23","author":"SR Hingorani","year":"2023","unstructured":"Hingorani SR. Epithelial and stromal co-evolution and complicity in pancreatic cancer. Nat Rev Cancer. 2023;23:57\u201377.","journal-title":"Nat Rev Cancer"},{"key":"3473_CR5","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554:544\u20138.","journal-title":"Nature"},{"key":"3473_CR6","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","volume":"27","author":"H Wang","year":"2021","unstructured":"Wang H, Mei Y, Luo C, Huang Q, Wang Z, Lu GM, et al. Single-cell analyses reveal mechanisms of cancer stem cell maintenance and epithelial-mesenchymal transition in recurrent bladder cancer. Clin Cancer Res. 2021;27:6265\u201378.","journal-title":"Clin Cancer Res"},{"key":"3473_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861\u201372.","journal-title":"Cell"},{"key":"3473_CR8","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19:23\u201336.","journal-title":"Nat Rev Clin Oncol"},{"key":"3473_CR9","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/ng.229","volume":"40","author":"LA Kiemeney","year":"2008","unstructured":"Kiemeney LA, Thorlacius S, Sulem P, Geller F, Aben KK, Stacey SN, et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat Genet. 2008;40:1307\u201312.","journal-title":"Nat Genet"},{"key":"3473_CR10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.eururo.2003.12.013","volume":"45","author":"MJ Ribal","year":"2004","unstructured":"Ribal MJ, Alcaraz A, Mengual L, Carrio A, Lopez-Guillermo A, Mallofre C, et al. Chromosomal high-polysomies predict tumour progression in T1 transitional cell carcinoma of the bladder. Eur Urol. 2004;45:593\u20139.","journal-title":"Eur Urol"},{"key":"3473_CR11","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","volume":"52","author":"H Kim","year":"2020","unstructured":"Kim H, Nguyen NP, Turner K, Wu S, Gujar AD, Luebeck J, et al. Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers. Nat Genet. 2020;52:891\u20137.","journal-title":"Nat Genet"},{"key":"3473_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles MA, Hurst CD. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat Rev Cancer. 2015;15:25\u201341.","journal-title":"Nat Rev Cancer"},{"key":"3473_CR13","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, et al. Interferon-dependent SLC14A1(+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell. 2022;40:1550\u201365 e7.","journal-title":"Cancer Cell"},{"key":"3473_CR14","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1159\/000019629","volume":"33","author":"I Sardi","year":"1998","unstructured":"Sardi I, Dal Canto M, Bartoletti R, Guazzelli R, Travaglini F, Montali E. Molecular genetic alterations of c-myc oncogene in superficial and locally advanced bladder cancer. Eur Urol. 1998;33:424\u201330.","journal-title":"Eur Urol"},{"key":"3473_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/6010","volume":"21","author":"KJ Wu","year":"1999","unstructured":"Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J, et al. Direct activation of TERT transcription by c-MYC. Nat Genet. 1999;21:220\u20134.","journal-title":"Nat Genet"},{"key":"3473_CR16","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nature01327","volume":"421","author":"N Gomez-Roman","year":"2003","unstructured":"Gomez-Roman N, Grandori C, Eisenman RN, White RJ. Direct activation of RNA polymerase III transcription by c-Myc. Nature. 2003;421:290\u20134.","journal-title":"Nature"},{"key":"3473_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.ccell.2018.02.003","volume":"33","author":"J Andricovich","year":"2018","unstructured":"Andricovich J, Perkail S, Kai Y, Casasanta N, Peng W, Tzatsos A. Loss of KDM6A activates super-enhancers to induce gender-specific squamous-like pancreatic cancer and confers sensitivity to BET inhibitors. Cancer Cell. 2018;33:512\u201326 e8.","journal-title":"Cancer Cell"},{"key":"3473_CR18","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer JS, Hoadley KA, Chism DD, Fan C, Tiganelli CJ, Wobker SE, et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc Natl Acad Sci USA. 2014;111:3110\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3473_CR19","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.eururo.2018.06.047","volume":"74","author":"DH Hovelson","year":"2018","unstructured":"Hovelson DH, Udager AM, McDaniel AS, Grivas P, Palmbos P, Tamura S, et al. Targeted DNA and RNA sequencing of paired urothelial and squamous bladder cancers reveals discordant genomic and transcriptomic events and unique therapeutic implications. Eur Urol. 2018;74:741\u201353.","journal-title":"Eur Urol"},{"key":"3473_CR20","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","volume":"78","author":"AG Robertson","year":"2020","unstructured":"Robertson AG, Groeneveld CS, Jordan B, Lin X, McLaughlin KA, Das A, et al. Identification of differential tumor subtypes of T1 bladder cancer. Eur Urol. 2020;78:533\u20137.","journal-title":"Eur Urol"},{"key":"3473_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38160-x","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ju L, Wang G, Qian K, Jin W, Li M, et al. DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. Nat Commun. 2023;14:2421.","journal-title":"Nat Commun"},{"key":"3473_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06446-7","volume":"15","author":"M Li","year":"2024","unstructured":"Li M, Yu J, Ju L, Wang Y, Jin W, Zhang R, et al. USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer. Cell Death Dis. 2024;15:44.","journal-title":"Cell Death Dis"},{"key":"3473_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45796-w","volume":"15","author":"J Ma","year":"2024","unstructured":"Ma J, Li L, Ma B, Liu T, Wang Z, Ye Q, et al. MYC induces CDK4\/6 inhibitors resistance by promoting pRB1 degradation. Nat Commun. 2024;15:1871.","journal-title":"Nat Commun"},{"key":"3473_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41587-020-00805-3","volume":"39","author":"DSC Butler","year":"2021","unstructured":"Butler DSC, Cafaro C, Putze J, Wan MLY, Tran TH, Ambite I, et al. A bacterial protease depletes c-MYC and increases survival in mouse models of bladder and colon cancer. Nat Biotechnol. 2021;39:754\u201364.","journal-title":"Nat Biotechnol"},{"key":"3473_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson AG, Kim J, Al-Ahmadie H, Bellmunt J, Guo G, Cherniack AD, et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell. 2017;171:540\u201356 e25.","journal-title":"Cell"},{"key":"3473_CR26","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature04296","volume":"439","author":"AH Bild","year":"2006","unstructured":"Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature. 2006;439:353\u20137.","journal-title":"Nature"},{"key":"3473_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ejca.2022.05.022","volume":"171","author":"Z Liu","year":"2022","unstructured":"Liu Z, Jin K, Zeng H, Shao F, Chang Y, Wang Y, et al. B7-H4 correlates with clinical outcome and immunotherapeutic benefit in muscle-invasive bladder cancer. Eur J Cancer. 2022;171:133\u201342.","journal-title":"Eur J Cancer"},{"key":"3473_CR28","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1158\/1078-0432.CCR-17-2687","volume":"24","author":"H Fu","year":"2018","unstructured":"Fu H, Zhu Y, Wang Y, Liu Z, Zhang J, Xie H, et al. Identification and validation of stromal immunotype predict survival and benefit from adjuvant chemotherapy in patients with muscle-invasive bladder cancer. Clin Cancer Res. 2018;24:3069\u201378.","journal-title":"Clin Cancer Res"},{"key":"3473_CR29","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","volume":"30","author":"A Lugli","year":"2017","unstructured":"Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H, et al. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol. 2017;30:1299\u2013311.","journal-title":"Mod Pathol"},{"key":"3473_CR30","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.ccell.2024.10.016","volume":"42","author":"H Hamidi","year":"2024","unstructured":"Hamidi H, Senbabaoglu Y, Beig N, Roels J, Manuel C, Guan X, et al. Molecular heterogeneity in urothelial carcinoma and determinants of clinical benefit to PD-L1 blockade. Cancer Cell. 2024;42:2098\u2013112 e4.","journal-title":"Cancer Cell"},{"key":"3473_CR31","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 2014;25:152\u201365.","journal-title":"Cancer Cell"},{"key":"3473_CR32","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun A, de Reynies A, Allory Y, Sjodahl G, Robertson AG, Seiler R, et al. A Consensus molecular classification of muscle-invasive bladder cancer. Eur Urol. 2020;77:420\u201333.","journal-title":"Eur Urol"},{"key":"3473_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138.","journal-title":"Nature"},{"key":"3473_CR34","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck J, Goossens S, Berx G. The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet. 2023;24:590\u2013609.","journal-title":"Nat Rev Genet"},{"key":"3473_CR35","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/s41585-023-00847-7","volume":"21","author":"CC Guo","year":"2024","unstructured":"Guo CC, Lee S, Lee JG, Chen H, Zaleski M, Choi W, et al. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nat Rev Urol. 2024;21:391\u2013405.","journal-title":"Nat Rev Urol"},{"key":"3473_CR36","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/s41556-025-01617-w","volume":"27","author":"Y Ueda","year":"2025","unstructured":"Ueda Y, Kiyonaka S, Selfors LM, Inoue K, Harada H, Doura T, et al. Intratumour oxidative hotspots provide a niche for cancer cell dissemination. Nat Cell Biol. 2025;27:530\u201343.","journal-title":"Nat Cell Biol"},{"key":"3473_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","volume":"640","author":"E Fiorini","year":"2025","unstructured":"Fiorini E, Malinova A, Schreyer D, Pasini D, Bevere M, Alessio G, et al. MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Nature. 2025;640:811\u201320.","journal-title":"Nature"},{"key":"3473_CR38","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41571-025-01058-2","volume":"22","author":"EW Thompson","year":"2025","unstructured":"Thompson EW, Redfern AD, Brabletz S, Berx G, Agarwal V, Ganesh K, et al. EMT and cancer: what clinicians should know. Nat Rev Clin Oncol. 2025;22:711\u201333.","journal-title":"Nat Rev Clin Oncol"},{"key":"3473_CR39","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41571-020-0422-y","volume":"18","author":"A Lugli","year":"2021","unstructured":"Lugli A, Zlobec I, Berger MD, Kirsch R, Nagtegaal ID. Tumour budding in solid cancers. Nat Rev Clin Oncol. 2021;18:101\u201315.","journal-title":"Nat Rev Clin Oncol"},{"key":"3473_CR40","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1111\/cas.12990","volume":"107","author":"K Fukumoto","year":"2016","unstructured":"Fukumoto K, Kikuchi E, Mikami S, Ogihara K, Matsumoto K, Miyajima A, et al. Tumor budding, a novel prognostic indicator for predicting stage progression in T1 bladder cancers. Cancer Sci. 2016;107:1338\u201344.","journal-title":"Cancer Sci"},{"key":"3473_CR41","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euo.2023.07.011","volume":"7","author":"M Eckstein","year":"2024","unstructured":"Eckstein M, Matek C, Wagner P, Erber R, Buttner-Herold M, Wild PJ, et al. Proposal for a novel histological scoring system as a potential grading approach for muscle-invasive urothelial bladder cancer correlating with disease aggressiveness and patient outcomes. Eur Urol Oncol. 2024;7:128\u201338.","journal-title":"Eur Urol Oncol"},{"key":"3473_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202416161","volume":"12","author":"X Li","year":"2025","unstructured":"Li X, Zou C, Wang C, Chang C, Lin Y, Liang S, et al. Non-invasive tumor budding evaluation and correlation with treatment response in bladder cancer: a multi-center cohort study. Adv Sci. 2025;12:e2416161.","journal-title":"Adv Sci"},{"key":"3473_CR43","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41591-024-02805-1","volume":"30","author":"E Garralda","year":"2024","unstructured":"Garralda E, Beaulieu ME, Moreno V, Casacuberta-Serra S, Martinez-Martin S, Foradada L, et al. MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nat Med. 2024;30:762\u201371.","journal-title":"Nat Med"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03473-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03473-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03473-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T10:17:40Z","timestamp":1785493060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03473-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8,20]]}},"alternative-id":["3473"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03473-3","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"assertion":[{"value":"16 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All the information from individual patients of Zhongshan Hospital has gained written informed consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Clinical Research Ethics Committee of Zhongshan Hospital and Fudan University (No. B2015-030). Written informed consent was obtained from each patient. The study was performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}